Company Filing History:
Years Active: 2023
Title: The Innovations of Shu-Wen Wan in Dengue Vaccine Development
Introduction: Shu-Wen Wan is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of vaccine development, particularly in the fight against dengue fever. His innovative work focuses on enhancing the efficacy of dengue vaccines through advanced compositions.
Latest Patents: Shu-Wen Wan holds a patent for a composition of a subunit dengue vaccine. This invention involves a fusion protein that connects delta C nonstructural protein 1 (NS1) to polypeptides of NS3c and/or consensus envelope protein domain III (cEDIII). The goal of this composition is to provide better protection against dengue virus (DENV) challenges while alleviating associated pathological effects. He has 1 patent to his name.
Career Highlights: Shu-Wen Wan is affiliated with National Cheng Kung University, where he conducts research and development in the field of immunology and vaccine technology. His work has been instrumental in advancing the understanding of dengue virus and improving vaccine formulations.
Collaborations: Shu-Wen Wan has collaborated with notable colleagues, including Yee-Shin Lin and Trai-Ming Yeh. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in vaccine development.
Conclusion: Shu-Wen Wan's contributions to the field of dengue vaccine development highlight his commitment to improving public health through innovative solutions. His work exemplifies the importance of research and collaboration in addressing global health challenges.